Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9WL6

ALECT2 type Ib filament from renal biopsy tissue of an individual with ALECT2 amyloidosis

Summary for 9WL6
Entry DOI10.2210/pdb9wl6/pdb
EMDB information66047
DescriptorLeukocyte cell-derived chemotaxin-2 (1 entity in total)
Functional Keywordsleukocyte chemotactic factor 2 amyloid filament, protein fibril
Biological sourceHomo sapiens (human)
Total number of polymer chains3
Total formula weight43781.18
Authors
Zheng, J.,Zheng, Y.,Shi, Y. (deposition date: 2025-09-02, release date: 2026-06-03)
Primary citationZheng, J.L.,Zheng, Y.X.,Chen, K.,Wang, S.,Liang, J.W.,Wang, S.X.,Yang, L.,Shi, Y.
Cryo-EM structures of ALECT2 filaments from human renal biopsies.
Nat Commun, 2026
Cited by
PubMed Abstract: Leukocyte chemotactic factor 2 is a recently identified amyloidogenic protein, whose abnormal aggregation defines a systemic amyloidosis termed ALECT2 amyloidosis. Due to the lack of reliable biomarkers, diagnosis relies primarily on histological demonstration and typing of amyloid deposits in renal biopsies. However, immunohistochemical detection of ALECT2 is often inconsistent, leading to diagnostic uncertainty. The underlying basis remains poorly understood, reflecting our limited knowledge of ALECT2 deposits. Here, using cryo-electron microscopy (cryo-EM), we determined the structures of ALECT2 filaments from renal biopsies of five living patients. Unlike filaments assembled from recombinant proteins in vitro, all 133 residues of mature LECT2 are incorporated into the filament cores, with native disulfide linkages preserved. The filaments consistently adopt the shared six-layered folds in all five patients, indicating a common mechanism of amyloidogenesis. Because all residues are incorporated into the fibril core, epitope accessibility is limited. This can explain variability in immunohistochemical detection and thus highlights the need for conformation-specific antibodies and antibody-independent detection strategies for improving diagnostic accuracy. This biopsy-based workflow not only expands the availability of patient-derived tissue for cryo-EM studies but also demonstrates the potential of cryo-EM as a tool for precise diagnosis of systemic amyloidosis.
PubMed: 42173881
DOI: 10.1038/s41467-026-73602-2
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (1.95 Å)
Structure validation

254587

PDB entries from 2026-06-03

PDB statisticsPDBj update infoContact PDBjnumon